Explainer: Why we needed a Covid-19 inquiry Explainer The first evidence session of the Covid-19 inquiry in the UK begins today. The inquiry is colossal, both in terms of what it’s expected to cover and in terms of the amount of money that’s been spent to put it in place. It will last at least until 2026. You might think no one wants [...]
The Covid-19 inquiry should be a battle for Johnson, not for the Cabinet Office Eliot Wilson With the Boris Johnson Covid-19 inquiry saga, the Cabinet Office picked the wrong hill on which to die. Its fight with the inquiry poses questions about morality and transparency, writes Eliot Wilson
Wuhan lab leak caused Covid-19 pandemic, investigation claims Coronavirus A Wuhan lab leak after deadly coronaviruses were spliced into a mutant superbug may have caused the global Covid-19 pandemic, a shock investigation has claimed. Chinese scientists at the Wuhan Institute of Virology were running a dangerous undercover programme of experimental bioresearch, the Sunday Times’ Insight team reports. The revelations come the week the UK [...]
Not ‘sufficient thought’ into stopping Covid-19, Chris Whitty tells inquiry June 22, 2023 Government “did not give sufficient thought” into stopping the pandemic in its tracks, Sir Chris Whitty has told the official Covid-19 inquiry. The chief medical officer for England has said options to stop a disease outbreak on the scale of coronavirus were not considered fully enough by ministers ahead of the crisis. Giving evidence today, [...]
FTSE 100 lifted by China Covid-19 easing rumours December 5, 2022 London’s FTSE 100 was bumped higher today as investors were buoyed by signs Beijing is reeling back its tough zero-Covid policy. The capital’s premier index jumped 0.15 per cent to 7,567.54 points, while the domestically-focused mid-cap FTSE 250 index, which is more aligned with the health of the UK economy, dipped 0.17 per cent to [...]
FTSE 100 weighed down by China Covid-19 jitters November 21, 2022 London’s FTSE 100 was today weighed down by the re-emergence of tough restrictions to tame Covid-19 in China over the weekend. The capital’s premier index edged 0.12 per cent lower to 7,376.85 points, while the domestically-focus mid-cap FTSE 250 index, which is more aligned with the health of the UK economy, climbed 0.68 per cent [...]
Cabinet minister: Ukraine War and Covid-19 to blame for local election beating May 7, 2023 Culture Secretary Lucy Frazer has blamed heavy Tory losses in the local elections on the pandemic and the Ukraine war. She also noted the Conservative Party had been in power for “a long time”. The Cabinet minister conceded that voters were “frustrated and angry”, but claimed Rishi Sunak was starting to regain the public’s trust. [...]
Pfizer and BioNTech countersue Moderna in Covid-19 patent row December 6, 2022 Pfizer and German partner BioNTech shot back at competitor Moderna last night in the latest jab in the Covid-19 vaccine patent lawsuit. The sparring over allegations from Moderna that Pfizer and BioNTech violated the rights its three patents it created prior to the pandemic has been ongoing since August. All three companies are also embroiled [...]
Mediclinic warns of price hikes as inflation and Covid-19 rattle healthcare November 16, 2022 Hospital operator Mediclinic has voiced concern over its ability to stave of price hikes as it undergoes a billion-pound takeover. The London-listed company, which was bought by a South African consortium for £3.7bn in August, said increasing economic uncertainty, rising inflation and the risk of further Covid-19 disruption is weighing on margins. “Increasing macro-economic uncertainty, [...]
AstraZeneca: Revenue boost despite welcome end of Covid-19 jab sales July 28, 2023 Britain’s biggest FTSE firm AstraZeneca reported an uptick in sales as oncology treatments helped pick up the slack from falling sales of Covid-19 medicines. The pharmaceutical company made over $22.2bn (£17.3bn) – a four per cent increase – during the first half of 2023, causing shares to spring over three per cent on market open [...]